Fund Holdings — Integral Health Asset Management, LLC

Total Portfolio Value:
$902.67M
Total Bought:
$301.96M
Total Sold:
$489.06M
Net Transaction:
-$187.09M
Notable People:
Bhagwan Jay Rao
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)1,550,0001,550,0000$107.01M$118.25M13.10%+$11.24M
Boston Scientific Corporation(BSX)550,000650,000+100,000$49.13M$65.57M7.26%+$16.45M
Cytokinetics, Incorporated(CYTK)1,000,0001,100,000+100,000$47.04M$44.21M4.90%-$2.83M
Tenet Healthcare Corporation(THC)400,000275,000-125,000$50.49M$36.99M4.10%-$13.50M
Mineralys Therapeutics, Inc.(MLYS)875,0002,300,000+1,425,000$10.77M$36.52M4.05%+$25.75M
Elevance Health, Inc.(ELV)065,000+65,000$0$28.27M3.13%+$28.27M
Novartis AGADR(NVS)0250,000+250,000$0$27.87M3.09%+$27.87M
Vera Therapeutics, Inc.CL A(VERA)1,150,0001,150,0000$48.63M$27.62M3.06%-$21.01M
Encompass Health Corporation(EHC)300,000270,000-30,000$27.70M$27.35M3.03%-$359.4K
Medtronic plcSHS(MDT)150,000300,000+150,000$11.98M$26.96M2.99%+$14.98M
Gilead Sciences, Inc.(GILD)200,000175,000-25,000$18.47M$19.61M2.17%+$1.13M
Baxter Intl Inc0500,000+500,000$0$17.11M1.90%+$17.11M
Fresenius Medical Care AGADR(FMS)600,000680,000+80,000$13.58M$16.93M1.88%+$3.35M
Neurocrine Biosciences, Inc.(NBIX)160,000150,000-10,000$21.84M$16.59M1.84%-$5.25M
Ascendis Pharma A/SADR(ASND)0100,000+100,000$0$15.59M1.73%+$15.59M
Edgewise Therapeutics, Inc.(EWTX)550,000675,000+125,000$14.69M$14.85M1.65%+$165.0K
BrightSpring Health Services, Inc.(BTSG)950,000775,000-175,000$16.18M$14.02M1.55%-$2.16M
CVS Health Corporation(CVS)500,000200,000-300,000$22.45M$13.55M1.50%-$8.89M
Alnylam Pharmaceuticals, Inc.(ALNY)45,00050,000+5,000$10.59M$13.50M1.50%+$2.91M
uniQure N.V.SHS(QURE)1,100,0001,250,000+150,000$19.43M$13.25M1.47%-$6.18M
Blueprint Medicines Corp275,000145,000-130,000$23.99M$12.83M1.42%-$11.15M
AbbVie Inc.(ABBV)060,000+60,000$0$12.57M1.39%+$12.57M
RadNet, Inc.(RDNT)0250,000+250,000$0$12.43M1.38%+$12.43M
GE HealthCare Technologies Inc.(GEHC)0150,000+150,000$0$12.11M1.34%+$12.11M
Krystal Biotech, Inc.(KRYS)55,00060,000+5,000$8.62M$10.82M1.20%+$2.20M
Inspire Medical Systems, Inc.(INSP)100,00065,000-35,000$18.54M$10.35M1.15%-$8.18M
Tarsus Pharmaceuticals, Inc.(TARS)350,000200,000-150,000$19.38M$10.27M1.14%-$9.11M
Penumbra, Inc.(PEN)035,000+35,000$0$9.36M1.04%+$9.36M
Edwards Lifesciences Corp0125,000+125,000$0$9.06M1.00%+$9.06M
Revolution Medicines, Inc.(RVMD)550,000250,000-300,000$24.06M$8.84M0.98%-$15.22M
McKesson Corporation(MCK)35,00012,000-23,000$19.95M$8.08M0.89%-$11.87M
MoonLake ImmunotherapeuticsCL A(MLTX)200,000200,0000$10.83M$7.81M0.87%-$3.02M
Teva Pharmaceutical Industries LimitedADS(TEVA)500,000500,0000$11.02M$7.68M0.85%-$3.33M
89bio Inc1,000,0001,050,000+50,000$7.82M$7.63M0.85%-$186.5K
Pfizer Inc.(PFE)0300,000+300,000$0$7.60M0.84%+$7.60M
Acadia Healthcare Company, Inc.(ACHC)300,000250,000-50,000$11.89M$7.58M0.84%-$4.32M
Masimo Corp045,000+45,000$0$7.50M0.83%+$7.50M
Waters Corporation(WAT)30,00020,000-10,000$11.13M$7.37M0.82%-$3.76M
Verona Pharma PlcADS0115,000+115,000$0$7.30M0.81%+$7.30M
DexCom, Inc.(DXCM)150,000100,000-50,000$11.67M$6.83M0.76%-$4.84M
REGENXBIO Inc.(RGNX)900,000925,000+25,000$6.96M$6.61M0.73%-$343.3K
Bristol-Myers Squibb Company(BMY)350,000100,000-250,000$19.80M$6.10M0.68%-$13.70M
Roivant Sciences Ltd.SHS(ROIV)0600,000+600,000$0$6.05M0.67%+$6.05M
Protara Therapeutics, Inc.(TARA)1,400,0001,400,0000$7.39M$5.96M0.66%-$1.43M
IQVIA Holdings Inc.(IQV)030,000+30,000$0$5.29M0.59%+$5.29M
CRISPR Therapeutics AGNAMEN AKT(CRSP)0150,000+150,000$0$5.10M0.57%+$5.10M
PTC Therapeutics, Inc.(PTCT)0100,000+100,000$0$5.10M0.56%+$5.10M
Alkermes plcSHS(ALKS)0150,000+150,000$0$4.95M0.55%+$4.95M
Dyne Therapeutics, Inc.(DYN)150,000450,000+300,000$3.53M$4.71M0.52%+$1.17M
Labcorp Holdings Inc.(LH)020,000+20,000$0$4.65M0.52%+$4.65M
Becton, Dickinson and Company(BDX)020,000+20,000$0$4.58M0.51%+$4.58M
Biohaven Ltd.(BHVN)0175,000+175,000$0$4.21M0.47%+$4.21M
Crinetics Pharmaceuticals In300,000125,000-175,000$15.34M$4.19M0.46%-$11.15M
Scholar Rock Holding Corporation(SRRK)375,000125,000-250,000$16.21M$4.02M0.45%-$12.19M
Alignment Healthcare, Inc.(ALHC)500,000200,000-300,000$5.63M$3.72M0.41%-$1.90M
Globus Medical, Inc.CL A(GMED)050,000+50,000$0$3.66M0.41%+$3.66M
BioNTech SEADS(BNTX)100,00040,000-60,000$11.39M$3.64M0.40%-$7.75M
Catalyst Pharmaceuticals Inc300,000150,000-150,000$6.26M$3.64M0.40%-$2.62M
BridgeBio Pharma, Inc.(BBIO)0100,000+100,000$0$3.46M0.38%+$3.46M
Sana Biotechnology, Inc.(SANA)2,000,0002,000,0000$3.26M$3.36M0.37%+$100.0K
The Cigna Group(CI)010,000+10,000$0$3.29M0.36%+$3.29M
Nurix Therapeutics, Inc.(NRIX)250,000275,000+25,000$4.71M$3.27M0.36%-$1.44M
Verastem, Inc.(VSTM)0500,000+500,000$0$3.02M0.33%+$3.02M
Oscar Health, Inc.CL A(OSCR)700,000200,000-500,000$9.41M$2.62M0.29%-$6.79M
Repligen Corporation(RGEN)40,00020,000-20,000$5.76M$2.54M0.28%-$3.21M
Jasper Therapeutics, Inc.(JSPR)650,000575,000-75,000$13.90M$2.47M0.27%-$11.42M
Arrowhead Pharmaceuticals, Inc.(ARWR)275,000175,000-100,000$5.17M$2.23M0.25%-$2.94M
Atyr Pharma Inc375,000700,000+325,000$1.36M$2.11M0.23%+$756.5K
Terns Pharmaceuticals Inc450,000700,000+250,000$2.49M$1.93M0.21%-$561.0K
Mereo BioPharma Group plcADS(MREO)1,000,000800,000-200,000$3.50M$1.80M0.20%-$1.70M
Rezolute, Inc.(RZLT)500,000500,0000$2.45M$1.45M0.16%-$1.00M
Cabaletta Bio, Inc.(CABA)500,000850,000+350,000$1.14M$1.18M0.13%+$42.3K
Tenax Therapeutics, Inc.(TENX)0167,000+167,000$0$1.09M0.12%+$1.09M
Alto Neuroscience, Inc.(ANRO)300,000400,000+100,000$1.27M$864.0K0.10%-$405.0K
Palatin Technologies Inc01,000,000+1,000,000$0$582.9K0.06%+$582.9K
Fate Therapeutics, Inc.(FATE)600,000700,000+100,000$990.0K$553.1K0.06%-$436.9K
Apellis Pharmaceuticals Inc
COM
420,0000-420,000$13.40M$0—-$13.40M
Arcellx Inc
COMMON STOCK
100,0000-100,000$7.67M$0—-$7.67M
AstraZeneca PLCADR(AZN)225,0000-225,000$14.74M$0—-$14.74M
Bruker Corporation(BRKR)100,0000-100,000$5.86M$0—-$5.86M
Cardinal Health, Inc.(CAH)250,0000-250,000$29.57M$0—-$29.57M
Centene Corporation(CNC)500,0000-500,000$30.29M$0—-$30.29M
COMPASS Pathways plcADS(CMPS)200,0000-200,000$756.0K$0—-$756.0K
The Cooper Companies, Inc.(COO)100,0000-100,000$9.19M$0—-$9.19M
Eli Lilly and Company(LLY)38,0000-38,000$29.34M$0—-$29.34M
Endeavour Silver Corp.(EXK)150,0000-150,000$8.43M$0—-$8.43M
Humana Inc.(HUM)40,0000-40,000$10.15M$0—-$10.15M
Illumina, Inc.(ILMN)40,0000-40,000$5.35M$0—-$5.35M
Inari Med Inc350,0000-350,000$17.87M$0—-$17.87M
Insulet Corporation(PODD)20,0000-20,000$5.22M$0—-$5.22M
Intuitive Surgical, Inc.(ISRG)40,0000-40,000$20.88M$0—-$20.88M
Janux Therapeutics, Inc.(JANX)200,0000-200,000$10.71M$0—-$10.71M
Keros Therapeutics, Inc.(KROS)450,0000-450,000$7.12M$0—-$7.12M
Kyverna Therapeutics, Inc.(KYTX)350,0000-350,000$1.31M$0—-$1.31M
Merck & Co., Inc.(MRK)200,0000-200,000$19.90M$0—-$19.90M
Pliant Therapeutics, Inc.(PLRX)300,0000-300,000$3.95M$0—-$3.95M
Quest Diagnostics Incorporated(DGX)130,0000-130,000$19.61M$0—-$19.61M
QuidelOrtho Corporation(QDEL)150,0000-150,000$6.68M$0—-$6.68M
Rhythm Pharmaceuticals, Inc.(RYTM)150,0000-150,000$8.40M$0—-$8.40M
Silence Therapeutics plcADS(SLN)200,0000-200,000$1.38M$0—-$1.38M
Page 1 of 2
Integral Health Asset Management, LLC — 13F Holdings — Q1 2025 | TickerTrail